PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Paul Rennie interviewed on Marcus Today Podcast., page-18

  1. 193 Posts.
    lightbulb Created with Sketch. 30
    The Marcus Report interviewer was a guest analyst on The Call today. PAR happened to be one of the stocks discussed on the show. Worth a look.

    The link wont work here, so just search for The Call and aus biz
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.